JPRN-UMIN000005276已完成未知
Efficacy and safety of Oral pirocarpin for xerostomia patients. - Study on xerostomia patients.
Faculty of Medicine, Kagawa University0 个研究点目标入组 40 人开始时间: 2011年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Contraindication to oral pilocarpine. Pregnancy or women with suspected pregnancy. The patients who could not be provided with informed consent. Unsuitability for the trial based on clinical judgement.
研究者
相似试验
尚未招募
不适用
The efficacy of pilocarpine for xerostomia induced by radiation therapy at different administration timing.xerostomiaJPRN-UMIN000010288Kawasaki Medical School20
已完成
2 期
Oral Pilocarpine tablets for advanced cancer patients with dry mouth.Cancer - Any cancerOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonxerostomiaACTRN12619000697189Mater Misericordiae Ltd18
尚未招募
不适用
Oral pilocarpine for treatment in patients with xerotic keratoconjunctivitisxerotic conjunctivitsJPRN-UMIN000002200Department of Ophthalmology and Visual neuroscience,The University of Tokushima, School of Medicine50
进行中（未招募）
不适用
CORAL – Cebranopadol versus morphine prolonged-release in patients with chronic moderate to severe pain related to cancerEUCTR2012-001316-35-BEGrünenthal GmbH655
进行中（未招募）
不适用
Clinical Trial comparing the ability of pain reduction and side effects of a new anti-pain medicament Cebranopadol and morphine sulfate Prolonged Release (PR) in patients suffering from chronic cancer pain of moderate to severe strength.EUCTR2012-001316-35-ATGrünenthal GmbH625